These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 9578160

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).
    Pfaller MA, Huband MD, Streit JM, Flamm RK, Sader HS.
    Int J Antimicrob Agents; 2018 Jun; 51(6):848-853. PubMed ID: 29410368
    [Abstract] [Full Text] [Related]

  • 25. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
    [Abstract] [Full Text] [Related]

  • 26. Antimicrobial resistance in gram-positive pathogens isolated in the UK between October 1996 and January 1997.
    Andrews J, Ashby J, Jevons G, Lines N, Wise R.
    J Antimicrob Chemother; 1999 May; 43(5):689-98. PubMed ID: 10382891
    [Abstract] [Full Text] [Related]

  • 27. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
    Jahansepas A, Ahangarzadeh Rezaee M, Hasani A, Sharifi Y, Rahnamaye Farzami M, Dolatyar A, Aghazadeh M.
    Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
    [Abstract] [Full Text] [Related]

  • 28. Multidrug-resistant gram-positive pathogens. An update on current microbiological patterns.
    Marchese A, Debbia EA, Bacca D, Balistreri G, Musolino B, Schito GC.
    Drugs; 1997 Oct; 54 Suppl 6():11-20. PubMed ID: 9474477
    [Abstract] [Full Text] [Related]

  • 29. Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
    Streit JM, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):307-10. PubMed ID: 15922534
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics.
    Elsner HA, Sobottka I, Feucht HH, Claussen M, Kaulfers PM, Laufs R, Mack D.
    Chemotherapy; 2000 Dec; 46(2):104-10. PubMed ID: 10671760
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Longitudinal surveillance on antibiogram of important Gram-positive pathogens in Southern China, 2001 to 2015.
    Xu Z, Xie J, Peters BM, Li B, Li L, Yu G, Shirtliff ME.
    Microb Pathog; 2017 Feb; 103():80-86. PubMed ID: 27894963
    [Abstract] [Full Text] [Related]

  • 36. Activity of a new glycopeptide antibiotic (LY333328) against enterococci and other resistant gram-positive organisms.
    Fraise AP, Andrews J, Wise R.
    J Antimicrob Chemother; 1997 Sep; 40(3):423-5. PubMed ID: 9338497
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.
    Johnson AP, Warner M, Livermore DM.
    J Antimicrob Chemother; 2002 Jul; 50(1):89-93. PubMed ID: 12096011
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.